Paxiril-Plus Tablet CR
Marketer
Austrex Healthcare
Salt Composition
Paroxetine (12.5mg) + Clonazepam (0.5mg)
Overview Paxiril-Plus Tablet CR
Paroxetine extended-release tablets are a prescription medication for managing depressive disorders. This combination drug elevates brain neurotransmitter levels, thereby improving mood and reducing excessive neuronal activity. It can be taken with or without food, ideally at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration precisely, as it carries a risk of dependence. Avoid missed doses; if one is missed, take it immediately upon remembering. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided due to potential withdrawal effects. Side effects may include nausea, vomiting, confusion, memory problems, decreased libido, delayed ejaculation, dizziness, and drowsiness. Avoid activities requiring alertness until the drug's effects are known. Report any unusual mood changes or worsening depression, as suicidal thoughts are a possibility. Exercise caution if you have liver disease. Disclose all other medications to your doctor, as interactions can alter efficacy or effects. Inform your doctor about pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Paxiril-Plus Tablet CR
There is no text provided to rephrase.
Uses of Paxiril-Plus Tablet CR
Major Depressive Disorder
Major Benefits of Paxiril-Plus Tablet CR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Paxiril-Plus CR tablets can be consumed with or without food; however, consistent daily timing is recommended for optimal results.
Common Side effects of Paxiril-Plus Tablet CR:
- Nausea
- Vomiting
- Diarrhea
- Confusion
- Memory impairment
- Uncoordinated body movements
- Drowsiness
- Tiredness
- Anorgasmia (decreased orgasm)
- Low sexual desire
- Delayed ejaculation
How to use Paxiril-Plus Tablet CR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Paxiril-Plus CR tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Paxiril-Plus Tablet CR works:
The extended-release tablet, Paxiril-Plus CR, contains a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Paxiril-Plus Tablet CR and alcohol is contraindicated due to safety concerns.
PregnancyUNSAFE
Using Paxiril-Plus CR tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician immediately, as research involving animals and pregnant humans indicates significant potential harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Paxiril-Plus tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Paxiril-Plus CR tablets.
KidneySAFE IF PRESCRIBED
The extended-release Paxiril-Plus tablet is likely safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended. Patients in the final stages of kidney disease may experience increased drowsiness with Paxiril-Plus tablet use.
LiverCAUTION
Patients with hepatic impairment should exercise caution when taking Paxiril-Plus CR tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Paxiril-Plus Tablet CR :
Should you forget to take a Paxiril-Plus CR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Paxiril-Plus Tablet CR
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |




